miR-351 promotes atherosclerosis in diabetes by inhibiting the ITGB3/PIK3R1/Akt pathway and induces endothelial cell injury and lipid accumulation

Abstract Background The miR-351 gene is significantly upregulated in diabetic mice with atherosclerosis. However, the mechanism by which its presence is important for the overall disease has not been elucidated. Therefore, this study will investigate the mechanism of miR-351 in the process of diabet...

Full description

Saved in:
Bibliographic Details
Main Authors: Hong Li (Author), Dan Song (Author), Qihui Liu (Author), Linlin Li (Author), Xiaoshi Sun (Author), Jiamei Guo (Author), Dianlian Li (Author), Ping Li (Author)
Format: Book
Published: BMC, 2022-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_5cdbfabe94ad4fb08d93b23f3f44b3e8
042 |a dc 
100 1 0 |a Hong Li  |e author 
700 1 0 |a Dan Song  |e author 
700 1 0 |a Qihui Liu  |e author 
700 1 0 |a Linlin Li  |e author 
700 1 0 |a Xiaoshi Sun  |e author 
700 1 0 |a Jiamei Guo  |e author 
700 1 0 |a Dianlian Li  |e author 
700 1 0 |a Ping Li  |e author 
245 0 0 |a miR-351 promotes atherosclerosis in diabetes by inhibiting the ITGB3/PIK3R1/Akt pathway and induces endothelial cell injury and lipid accumulation 
260 |b BMC,   |c 2022-09-01T00:00:00Z. 
500 |a 10.1186/s10020-022-00547-9 
500 |a 1076-1551 
500 |a 1528-3658 
520 |a Abstract Background The miR-351 gene is significantly upregulated in diabetic mice with atherosclerosis. However, the mechanism by which its presence is important for the overall disease has not been elucidated. Therefore, this study will investigate the mechanism of miR-351 in the process of diabetes mellitus with atherosclerosis through miR-351 gene knockout mice. Methods In this study, miR-351−/− C57BL/6 mice were first induced to form a type 2 diabetes mellitus model with atherosclerosis by STZ injection and a high-fat diet. Pathological tests (oil red O, HE, and Masson staining) combined with biochemical indices (TC, TG, LDL-C, HDL-C, TNF-α, hs-CRP, NO, SOD, MDA, CAT, and GSH-Px) were performed to evaluate the pathological degree of atherosclerosis in each group. Mouse aortic endothelial cells were treated with oxidized low-density lipoprotein (ox-LDL) and 30 mM glucose to establish a diabetic atherosclerosis cell model. Combined with cell oil red O staining and flow cytometry, the effects of silencing miR-351 on lipid accumulation and cell apoptosis in the diabetic atherosclerosis cell model were determined. Fluorescence in situ hybridization was used to detect the localization and transcription levels of miR-351 in cells. The target genes of miR-351 were predicted by bioinformatics and verified by dual-luciferase activity reporting. Western blotting was used to detect the expression levels of phosphorylated inosine 3-kinase regulatory subunit 1 (PIK3R1)/serine/threonine kinase 1 (Akt) and apoptosis-related proteins after transfection with integrin subunit β3 (ITGB3) small interfering ribonucleic acid (siRNA). Results The expression of the miR-351 gene was significantly increased in the high-fat wild-type (HWT) group, and its expression was significantly decreased in the knockout mice. Silencing miR-351 effectively alleviated atherosclerosis in mice. The levels of miR-351 expression, apoptosis, lipid accumulation, and oxidative stress in ox-LDL + high glucose-induced endothelial cells were significantly increased. These phenomena were effectively inhibited in lentivirus-infected miR-351-silenced cell lines. Bioinformatics predicted that miR-351-5p could directly target the ITGB3 gene. Transfection of ITGB3 siRNA reversed the downregulation of apoptosis, decreased oil accumulation, and decreased oxidative stress levels induced by miR-351 silencing. In addition, it inhibited the activation of the PIK3R1/Akt pathway. Conclusion Silencing miR-351 upregulates ITGB3 and activates the PIK3R1/Akt pathway, thereby exerting anti-apoptosis and protective effects on endothelial cells. 
546 |a EN 
690 |a Atherosclerosis 
690 |a Diabetes mellitus 
690 |a miR-351 
690 |a ITGB3 
690 |a Aortic endothelial cells 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Biochemistry 
690 |a QD415-436 
655 7 |a article  |2 local 
786 0 |n Molecular Medicine, Vol 28, Iss 1, Pp 1-21 (2022) 
787 0 |n https://doi.org/10.1186/s10020-022-00547-9 
787 0 |n https://doaj.org/toc/1076-1551 
787 0 |n https://doaj.org/toc/1528-3658 
856 4 1 |u https://doaj.org/article/5cdbfabe94ad4fb08d93b23f3f44b3e8  |z Connect to this object online.